Loading...
Dyslipidemia causes overestimation of plasma mitotane measurements
Mitotane (o,p′-DDD) is the standard treatment for advanced adrenocortical carcinoma (ACC). Monitoring of plasma mitotane levels is recommended to look for a therapeutic window between 14 and 20mg/L, but its positive predictive value requires optimization. We report the case of an ACC patient with a...
Na minha lista:
| Udgivet i: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Bioscientifica Ltd
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4901334/ https://ncbi.nlm.nih.gov/pubmed/27298727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-15-0135 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|